The first baby escapes blood cancer through genetic modification

Doctors say that the baby Layla Richards escapes leukemia is almost a miracle, and they are like "on the moon" when the treatment gives a satisfactory result.

Cure blood cancer by regulating genes

Baby Layla, 1 year old, was found to have leukemia at 3 months of age. The baby was treated by doctors at Great Ormond Street Hospital in the UK (GOSH) with immune-modifying immune cells after the baby failed to respond to conventional treatments.

Only after 2 months, the baby has no trace of the disease and is now discharged.

"Her leukemia is very dangerous and her response to this treatment is almost a miracle" , Paul Veys - professor at GOSH and head of the treatment group for her Layla, said at the press conference. November 5.

"Since this is the first time this therapy has been used, we do not know whether it will be effective or at all effective, so we like the moon to achieve this result," Veys added. .

Baby Layla Richards - (Photo: PA).

According to The Guardian, gene therapy cell therapy was co-researched by scientists at GOSH and University College London (UCL) and French biotechnology company Cellectis. Cellectis is currently funding clinical trials scheduled to begin next year.

Their approach is as follows : adding new genes to healthy immune cells called T cells - leukemia weapons, then using gene editing technology called TALEN to turn T cells into should be invisible to anti-leukemia drugs (because if they encounter this drug, they will be destroyed). After that, T cells will search and destroy cancer cells.

According to BBC, although it is too early to affirm that Layla has completely cured, baby therapy is making a big impact in medical research.

This technology also made a big breakthrough in the fight against leukocytes, specifically the teacher Paul Veys said this one of the most remarkable things he has seen in the past 20 years.

Leukemia , also known as leukemia or leukemia , is a type of malignant cancer. The cause of the disease has not been determined but may be due to environmental impacts (chemical pollution or radioactive contamination) or genetics.

Currently there are a number of treatments, but the effect is not high, mainly chemotherapy, radiotherapy or bone marrow replacement of patients with bone marrow of a donor with appropriate bone marrow (preferably people with the same bloodline as the sick).

However, despite any method of treatment, the probability of success is very low, only about 10% and even if it is successful, the possibility of relapse is also very large (about 3-5 years).